Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Enterprise Value across 17 years of filings, most recently posting $92.9 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 175.51% year-over-year to $92.9 million; the TTM figure through Jun 2026 stood at $92.9 million (up 175.51% YoY), while the FY2025 annual figure was $47.7 million, up 222.7% from the prior year.
• Enterprise Value came in at $92.9 million for Q2 2026 at Cumberland Pharmaceuticals, up from $37.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $92.9 million in Q2 2026 to a low of $159293.7 in Q3 2024.
• Average Enterprise Value over 5 years is $22.6 million, with a median of $13.5 million recorded in 2022.
• Year-over-year, Enterprise Value tumbled 98.02% in 2024 and soared 19454.31% in 2025.
• Over 5 years, Enterprise Value stood at $12.3 million in 2022, then plunged by 46.12% to $6.6 million in 2023, then jumped by 123.75% to $14.8 million in 2024, then soared by 222.7% to $47.7 million in 2025, then jumped by 94.56% to $92.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $92.9 million in Q2 2026, $37.4 million in Q1 2026, and $47.7 million in Q4 2025.